Company Filing History:
Years Active: 2025
Title: Kah-Hoe Pierce Chow: Innovator in Cancer Treatment Classification
Introduction
Kah-Hoe Pierce Chow is a notable inventor based in Singapore, recognized for his contributions to cancer treatment methodologies. His innovative approach focuses on classifying cancer patients to optimize their treatment options, particularly for hepatocellular carcinoma (HCC).
Latest Patents
Chow holds a patent titled "Method for classifying cancer patients into appropriate hepatocellular carcinoma treatment groups and compounds for treating the patient." This patent outlines a method for predicting treatment responses in cancer patients by measuring immune marker expressions in leukocyte samples. The classification distinguishes between sustainable responders and transient/non-responders to selective internal radiation therapy (SIRT). The method aims to enhance treatment efficacy by tailoring therapies based on individual patient profiles.
Career Highlights
Kah-Hoe Pierce Chow is affiliated with Singapore Health Services Pte Ltd, where he applies his expertise in oncology and patient care. His work has significantly impacted the field of cancer treatment, providing new insights into patient management and therapy optimization.
Collaborations
Chow collaborates with esteemed colleagues such as Suk Peng Chew and Salvatore Albani, contributing to a multidisciplinary approach in cancer research and treatment.
Conclusion
Kah-Hoe Pierce Chow's innovative methods in classifying cancer patients represent a significant advancement in personalized medicine. His work continues to influence the landscape of cancer treatment, offering hope for improved patient outcomes.